Fludeoxyglucose F 18 (fludeoxyglucose f-18) NDC 24562-001

NDC codes

FDA NDC Directory

Product NDC (as listed)24562-001Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24562-0001Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
24562-001-30	24562000130	30 mL in 1 VIAL, GLASS (24562-001-30)Marketed from May 14, 2015

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fludeoxyglucose F 18Suffix: F 18
Generic name (nonproprietary): fludeoxyglucose f-18
Active ingredients: Fludeoxyglucose f-18 — 300 mCi/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Biomedical Research Foundation of Northwest Louisiana
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203710
Marketing start: May 14, 2015
Listing expires: Dec 31, 2027
Other FDA classes: Radiopharmaceutical Activity (Mechanism)
Identifiers: Product ID 24562-001_fc81c6d7-e5da-4d87-8acb-5c7380c75efdSPL ID fc81c6d7-e5da-4d87-8acb-5c7380c75efdSPL set ID 1deaaa92-1c98-4295-8aa6-7a70bc29f55dUNII 0Z5B2CJX4D
Pharmacologic class: Radioactive Diagnostic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N424562000130 followed by a unit qualifier and the quantity

Package 24562-0001-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 10, 2026.

Indications (excerpt from the label)

Fludeoxyglucose F 18 Injection USP is indicated for positron emission tomography (PET) imaging in the following settings: Fludeoxyglucose F 18 Injection USP is indicated for positron emission tomography (PET) imaging in the following settings: Oncology: For assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer. Cardiology: For the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function in patients with coronary artery disease and left ventricular dysfunction, when …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)